Review
Published on 24 Jun 2024
Multifaceted roles of IKZF1 gene, perspectives from bench to bedside
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1383419
- 1,316 views
Type at least 3 characters
1,744 articles
Articles
Original Research
Published on 24 Jun 2024
Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1402992
- 2,003 views
Brief Research Report
Published on 24 Jun 2024
Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1391743
- 1,098 views
- 2 citations
Original Research
Published on 24 Jun 2024
Development and validation of a nomogram to predict poor efficacy of imatinib in the treatment of newly diagnosed chronic phase chronic myeloid leukemia patients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1418417
- 586 views
Editorial
Published on 21 Jun 2024
Editorial: The emerging role of liquid biopsies in hematologic disorders
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1437621
- 459 views
Original Research
Published on 21 Jun 2024
Efficacy and safety analysis of combination therapy based on mitoxantrone hydrochloride liposome injection (Lipo-MIT) in relapsed/refractory NK/T-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1396819
- 861 views
Review
Published on 20 Jun 2024
Myelofibrosis and allogeneic transplantation: critical points and challenges
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1396435
- 1,634 views
Case Report
Published on 20 Jun 2024
Case report: Splenic inflammatory pseudotumor-like follicular dendritic cell sarcoma (IPT-like FDCS): a trial of immunotherapy and review of the literature
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1360726
- 683 views
- 1 citation
Original Research
Published on 19 Jun 2024
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1389345
- 1,440 views
Original Research
Published on 13 Jun 2024
No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine—a prospective multicenter study by the Polish Adult Leukemia Group
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1404322
- 1,199 views
Case Report
Published on 13 Jun 2024
Case report: Clinical features of pediatric acute myeloid leukemia presenting with cardiac tamponade: a case series study and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1391768
- 896 views
Original Research
Published on 13 Jun 2024
Complete elimination of hyperleukocytosis risk in AML through early high-quality disease remission
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1412583
- 970 views
- 1 citation
Original Research
Published on 11 Jun 2024
Risk score constructed with neutrophil extracellular traps-related genes predicts prognosis and immune microenvironment in multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1365460
- 1,417 views
Original Research
Published on 11 Jun 2024
Liposomes have a direct effect on multiple myeloma: a Mendelian randomization study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1404744
- 1,731 views
Review
Published on 11 Jun 2024
Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1404351
- 1,840 views
Original Research
Published on 06 Jun 2024
Performance of MYC, BCL2, and BCL6 break-apart FISH in small biopsies with large B-cell lymphoma: a retrospective Cytopathology Hematopathology Interinstitutional Consortium study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1408238
- 1,172 views